Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells
Nils-Petter Rudqvist, Karsten A. Pilones, Claire Lhuillier, et al.
Cancer Immunology Research (2017) Vol. 6, Iss. 2, pp. 139-150
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti, Nils-Petter Rudqvist, Encouse B. Golden, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1845-1851
Open Access | Times Cited: 761
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 617
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae, Kyle W. Becker, Plamen P. Christov, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 3, pp. 269-278
Open Access | Times Cited: 545
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
María E. Rodríguez-Ruiz, Claire Vanpouille‐Box, Ignacio Melero, et al.
Trends in Immunology (2018) Vol. 39, Iss. 8, pp. 644-655
Open Access | Times Cited: 407
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran, Gregory L. Beatty, Stephanie K. Dougan
Gastroenterology (2019) Vol. 156, Iss. 7, pp. 2056-2072
Open Access | Times Cited: 382
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
Claire Lhuillier, Nils-Petter Rudqvist, Olivier Elemento, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 221
Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 12, pp. 729-745
Closed Access | Times Cited: 207
CAR T cells for brain tumors: Lessons learned and road ahead
David Akhavan, Darya Alizadeh, Dongrui Wang, et al.
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 60-84
Open Access | Times Cited: 185
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed I. Younes, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000537-e000537
Open Access | Times Cited: 157
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Ravi Patel, Reinier Hernandez, Peter M. Carlson, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 602
Open Access | Times Cited: 155
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Xueguang Lu, Lei Miao, Wenting Gao, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 556
Open Access | Times Cited: 152
Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation
Shisuo Du, Genwen Chen, Ping Yang, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 112, Iss. 5, pp. 1243-1255
Closed Access | Times Cited: 135
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu, et al.
Science Immunology (2022) Vol. 7, Iss. 72
Open Access | Times Cited: 95
Radiation, inflammation and the immune response in cancer
Kelly J. McKelvey, Amanda L. Hudson, Michael Back, et al.
Mammalian Genome (2018) Vol. 29, Iss. 11-12, pp. 843-865
Open Access | Times Cited: 149
The Reciprocity between Radiotherapy and Cancer Immunotherapy
Yifan Wang, Zhi-Gang Liu, Hengfeng Yuan, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 6, pp. 1709-1717
Open Access | Times Cited: 129
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non–Small-cell Lung Cancer
Dwight H. Owen, Lai Wei, Erin M. Bertino, et al.
Clinical Lung Cancer (2018) Vol. 19, Iss. 6, pp. e893-e900
Open Access | Times Cited: 126
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
Florian Wirsdörfer, Simone de Leve, Verena Jendrossek
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 24-24
Open Access | Times Cited: 125
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity
Sangeetha Palakurthi, Mari Kuraguchi, Sima J. Zacharek, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 9, pp. 1457-1471
Open Access | Times Cited: 121
Type I IFN protects cancer cells from CD8+ T cell–mediated cytotoxicity after radiation
Jianzhou Chen, Yunhong Cao, Boštjan Markelc, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4224-4238
Open Access | Times Cited: 115
The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T‐Cell Repertoire
Shubhankar Nath, Girgis Obaid, Tayyaba Hasan
Photochemistry and Photobiology (2019) Vol. 95, Iss. 6, pp. 1288-1305
Open Access | Times Cited: 112
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads
Danielle M. Lussier, Elise Alspach, Jeffrey P. Ward, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 24
Open Access | Times Cited: 95
Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
Ruben S. A. Goedegebuure, Leonie K. de Klerk, Adam J. Bass, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 92
The Liver–Immunity Nexus and Cancer Immunotherapy
James Lee, Michael D. Green, Laura A. Huppert, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 1, pp. 5-12
Open Access | Times Cited: 85
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Simone de Leve, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
Joel Kidman, Nicola Principe, Mark Watson, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top